CRNX vs IR · rev $35.9M vs P/E 49, rev $3.90B
Crinetics Pharmaceuticals Inc (CRNX) versus Ingersoll Rand Inc (IR) — a side-by-side from cached financials, not a winner call.
Crinetics Pharmaceuticals Inc (CRNX) is a biotechnology company listed on US.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Latest reported CRNX revenue for 2026-06-30 was $35.9M. Net income was -$248.7M. CRNX currently screens at market cap $2.76B.
Latest reported IR revenue for 2026-06-30 was $3.90B. Net income was $448.9M. IR currently screens at market cap $28.27B and trailing P/E 48.8.
CRNX currently screens at market cap $2.76B. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Not investment advice. Open the CRNX and IR stock pages for the full models.
Not investment advice.